Cancer/Gene Therapy

Retroviral Vector Effective Against Brain Tumors

Published in Gene Therapy Weekly, February 13th, 1995

At the 17th Annual Bristol-Myers Squibb Cancer Research Symposium, R. Michael Blaese of the U.S. National Cancer Institute shared the results of experimental therapies involving the introduction of genes that alter the sensitivity of tumors to various drugs.

The technique represents an indirect gene therapy approach to cancer that Blaese says has already met with some success.

Blaese described suicide genes to those in attendance at the symposium, which was sponsored by the University of California, Los Angeles (UCLA), Extension and the Jonsson Comprehensive Cancer Center at UCLA. These genes encode for relatively benign gene products that activate...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (1995-02-13)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry